TWO SIGMA INVESTMENTS, LP
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1179392
NEW YORK, NY
Position in RXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,307,924
-$175,663 QoQ
Shares Held
3,353,658
-17.5% QoQ
Ownership
0.626%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 344 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. RXRX ranks #77 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in RXRX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,307,924 | 3,353,658 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,483,587 | 4,066,315 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,577,253 | 3,075,123 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,959,928 | 2,450,805 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,909,133 | 1,167,813 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,097,391 | 1,152,626 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,225,040 | 1,660,509 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,526,193 | 1,597,298 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,696,815 | 1,426,242 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,937,905 | 896,480 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,251,830 | 532,640 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,001,286 | 392,325 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $1,388,313 | 208,143 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $563,624 | 73,103 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $1,432,937 | 200,131 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||